SUSMED,Inc. (TYO:4263)
Japan
· Delayed Price · Currency is JPY 618.00
-5.00 (-0.80%)
Jun 18, 2025, 3:30 PM JST
SUSMED,Inc. Revenue
SUSMED,Inc. had revenue of 345.00M JPY in the quarter ending March 31, 2025, with 721.43% growth. This brings the company's revenue in the last twelve months to 453.00M, up 33.24% year-over-year. In the fiscal year ending June 30, 2024, SUSMED,Inc. had annual revenue of 342.00M, down -35.47%.
Revenue (ttm)
453.00M
Revenue Growth
+33.24%
P/S Ratio
22.94
Revenue / Employee
11.62M
Employees
39
Market Cap
10.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 342.00M | -188.00M | -35.47% |
| Jun 30, 2023 | 530.00M | 214.00M | 67.72% |
| Jun 30, 2022 | 316.00M | 201.00M | 174.78% |
| Jun 30, 2021 | 115.00M | 81.00M | 238.24% |
| Jun 30, 2020 | 34.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |